Vertex Pharmaceuticals Additions for tax positions of prior years remained flat by 0.0% to $1.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.0%, from $1.15M to $1.30M. Over 2 years (FY 2023 to FY 2025), Additions for tax positions of prior years shows a downward trend with a -71.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Frequent increases may signal poor historical tax planning or unexpected scrutiny from tax authorities.
Represents additions to the reserve for uncertain tax positions related to tax filings from previous years. This often r...
Standard component of the 'Rollforward of Unrecognized Tax Benefits' table.
other_unrecognized_tax_benefits_increases_resulting_from_bb8d5f| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $62.50M | $4.60M | $5.20M |
| YoY Change | — | -92.6% | +13.0% |